Alerts will be sent to your verified email
Verify Email
ORCHPHARMA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, manufacturing, and marketing. They offer a wide range of pharmaceutical solutions and have a global presence through strategic alliances.
Orchid Pharma major competitors are Guj. Themis Biosyn, Gufic Biosciences, Unichem Lab, Zota Health Care, Panacea Biotec, Indoco Remedies, Novartis.
Market Cap of Orchid Pharma is ₹3,505 Crs.
While the median market cap of its peers are ₹2,787 Crs.
Orchid Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep | Sep Dec | ||||||||||||||||
| Investor Presentation | May | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun Aug Sep Dec | Mar Sep Dec | |||||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
